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Fine-tuning of insulin release from pancreatic β-cells is essential to maintain blood glucose
homeostasis. Here, we report that insulin secretion is regulated by a circular RNA containing
the lariat sequence of the second intron of the insulin gene. Silencing of this intronic circular
RNA in pancreatic islets leads to a decrease in the expression of key components of the
secretory machinery of β-cells, resulting in impaired glucose- or KCl-induced insulin release
and calcium signaling. The effect of the circular RNA is exerted at the transcriptional level and
involves an interaction with the RNA-binding protein TAR DNA-binding protein 43 kDa (TDP-
43). The level of this circularized intron is reduced in the islets of rodent diabetes models and
of type 2 diabetic patients, possibly explaining their impaired secretory capacity. The study of
this and other circular RNAs helps understanding β-cell dysfunction under diabetes condi-
tions, and the etiology of this common metabolic disorder.
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C ircular RNAs were first observed in eukaryotes by electronmicroscopy over 40 years ago1. However, it is onlyrecently, with the advent of modern RNA-sequencing
techniques and the use of unbiased computational approaches,
that circular RNAs (circRNAs) were recognized to constitute a
substantial fraction of the eukaryotic transcriptome2–4. CircRNAs
are usually generated from precursor mRNAs of protein-coding
genes but lack the 5′Cap and polyA tail. Exonic and exonic-
intronic circRNAs are formed by backsplicing and thus display
non-colinear 3′–5′ junctions; whereas intronic circRNAs typically
derive from spliced introns (lariats) circularized by non-colinear
2′–5′ junctions at the 5′ and branchpoint nucleotides. As a result,
the same gene locus can produce different exon/intron-contain-
ing circRNAs. These covalently closed RNAs are stable and
resistant to exonuclease degradation. They can be cell-specific and
conserved between species. CircRNAs affect cellular processes by
modulating gene transcription, splicing, and translation, and are
emerging as important players in the development of a wide
range of diseases2–4.
Pancreatic β-cells, located within the islets of Langerhans,
secrete insulin in response to a rise in nutrients or other non-
metabolic stimuli and play a central role in blood glucose
homeostasis. Dysfunction or loss of these cells can lead to chronic
hyperglycemia and to the development of different forms of
diabetes mellitus5. Thus, an in depth understanding of the
mechanisms controlling insulin release is essential to elucidate the
etiology of this very common metabolic disease. We recently
showed that human and mouse pancreatic islets express numer-
ous circRNAs, some of which participate in the regulation of
β-cell activities6. Indeed, the exonic circRNAs circHIPK3 and
ciRS-7/CDR1as were found to modulate the expression of genes
required for optimal insulin secretion and β-cell mass
expansion6,7. Interestingly, the levels of both circHIPK3 and ciRS-
7/CDR1as are diminished in the islets of diabetic db/db mice6,
suggesting that lower amounts of these circRNAs contribute to
the failure of β-cells to release enough insulin to cover the
organisms needs in these severely obese and insulin resistant
animals8.
In our previous study, we investigated a group of already
annotated and ubiquitously expressed circRNAs6. However, other
circRNAs may originate from important genes expressed in
pancreatic islets and may have been missed in previous analyses.
These circRNAs may be required for the secretory activity, pro-
liferation, and/or survival of β-cells, and could be dysregulated in
the islets of diabetic individuals and contribute to the functional
β-cell mass impairment characteristic of diabetes
pathophysiology5,9. In this work, we show an unbiased search for
all potential circular transcripts present in pancreatic islets that
led to the discovery of previously undetected circRNAs. Our
analysis identifies a number of circRNAs originating from key β-
cell genes, and reveals that a conserved intronic circRNA derived
from insulin pre-mRNA is necessary for optimal insulin secre-
tion. Indeed, its deficiency alters the expression of several genes
involved in insulin exocytosis, as well as calcium signaling, and
thus impairs the secretory activity of rat and human β-cells. The
intronic circRNA is mainly localized in the nucleus and exerts its
function by interacting with the RNA-binding protein TDP-43.
Furthermore, the level of this circRNA is decreased in the islets of
rodents and humans with type 2 diabetes, suggesting that it may
contribute to the development of the disease.
Results
Identification of circRNAs generated from key β-cell genes.
Taking advantage of a dedicated microarray platform containing
probes spanning over the predicted circular junctions of
annotated transcripts, we previously identified more than 3000
circRNAs in pancreatic islets6. A major limitation of this meth-
odology is that it can only detect circRNAs that are already
annotated in other datasets. To circumvent this problem and
obtain a comprehensive picture of all circRNAs present in islet
cells, we used a two-algorithm computational approach to de
novo annotate potential circular transcripts detectable in high-
throughput RNA-sequencing data from mouse islets (GEO
accession GSE92602)10. This computational approach led to the
prediction of 15,925 putative circRNAs (file provided in the GEO
accession GSE134699), which included circRNAs generated from
key β-cell genes such as Ins1, Ins2, Chga, Chgb, Gck, Glp1r, Pcsk1,
Pcsk2, and Slc30a85,11 (Supplementary Table 1). Because of the
essential role played by insulin in β-cell function and blood
glucose homeostasis5, we decided to focus on circRNAs origi-
nating from the insulin genes. Since the Ins1 gene is not con-
served in humans, we elected to study in more detail the
circRNAs including sequences of the insulin 2 (Ins2) gene, which
is the rodent orthologue of the human insulin (INS) gene12. Our
computational annotation identified three potential circRNAs
produced from the Ins2 gene (Supplementary Table 1). Interest-
ingly, the predicted circRNAs included sequences belonging to
intron 2. We first verified by RT-qPCR the existence of these
circRNAs in mouse, rat, and human islets using divergent primers
designed to amplify circularized transcripts13,14 (Supplementary
Fig. 1). Gel electrophoresis revealed the amplification of two or
more qPCR products in DNase-treated and reverse-transcribed
islet RNA from each of the three species (Fig. 1a). The presence of
multiple PCR products amplified with ci-Ins divergent primers
may potentially be due to the recognition of multiple branch-
points as described previously15. Sequencing of these qPCR
products indicated two common types of non-colinear junctions
between species corresponding to the lariat or to the totality (full
length) of the second intron of the insulin pre-mRNA (Fig. 1b
and Supplementary Fig. 2). The junction loci in mouse were
similar to two of the computationally predicted Ins2 circRNAs:
the lariat-derived circRNA_11718 and the full length-derived
circRNA_03986 (Supplementary Table 1). We next designed
qPCR over-junction primers that do not cross-react with the
corresponding insulin pre-mRNA and specifically amplify the
lariat-derived transcripts of the second intron of mouse or rat
Ins2 (ci-Ins2), or of human INS (ci-INS) (Fig. 1c). We decided to
focus on the lariat-derived circRNA despite its relatively low
abundance compared to its parent gene (Fig. 2a, b) since this class
of circRNAs has been shown to play important regulatory roles in
other cell types13,16–18. An estimation of the number of tran-
scripts (Supplementary Table 2) revealed that ci-Ins2 is about five
times less abundant compared to circHIPK3 (one of the most
abundant circRNAs present in β-cells6) but is twenty times more
abundant than ciRS-7 (a circRNA that has been reported to
regulate insulin secretion6,7).
ci-Ins2 is stable and exclusively detected in β-cells. We next
verified the circularity of the ci-Ins2 and ci-INS transcripts. Since
circRNAs are not polyadenylated19, they should not be efficiently
reverse-transcribed using oligo-dT primers. Indeed, while poly-
adenylated linear insulin mRNA of mouse, rat, and human were
equally well amplified from islet cDNAs produced with oligo-dT
or with random primers, ci-Ins2 and ci-INS could be efficiently
amplified only using random primers (Fig. 2c). Moreover, ci-Ins2
was poorly amplified in polyA-enriched rat islet RNA in contrast
to Ins2 (Fig. 2d). These observations confirm the absence of
polyA tails in these lariat transcripts in the three species. To
further verify the circularity of ci-Ins2 and ci-INS, we tested their
resistance to RNase R, an exoribonuclease that digests linear but
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not lariat or circRNAs20. After treating islet RNA with this
enzyme, we found that the rat ci-Ins2 is about 20 times more
resistant to RNase R degradation compared to the linear Ins2
mRNA (Fig. 2e), confirming the circularity of the intronic
sequence. Similar findings were obtained with the human ci-INS
and INS mRNA (Fig. 2e). Intron lariats are generated during
splicing and are usually degraded within minutes21. To assess
whether ci-Ins2 remains stable after Ins2 pre-mRNA splicing, we
measured its level in rat islet cells treated with the transcription
inhibitor actinomycin D. We found that the level of the lariat
derived from intron 2 remained constant for at least 4 h. In
contrast, intron 1 of Ins2 pre-mRNA was substantially degraded
within 10 min (Fig. 2f).
We then verified the level of ci-Ins2 and its parent gene Ins2 in
rat tissues and islet cells. As expected, Ins2 and ci-Ins2 were only
present in pancreatic islets (Fig. 3a, b). Among islet cells, ci-Ins2
was found to be highly enriched in β-cells (99% of insulin-
positive cells) and was only marginally detected in the fraction
containing α-cells (89% of glucagon-positive cells) (Fig. 3c). The
presence of low levels of the circRNA in the α-cell-enriched
fraction is most probably due to the few contaminating β-cells as
small amounts of Ins2 were also detected (Fig. 3c).
ci-Ins2 and ci-INS are required for optimal insulin secretion.
We next examined the role of ci-Ins2 in the regulation of β-cell
function and mass. For this purpose, we knocked down ci-Ins2 in
rat islet cells using an antisense LNA oligonucleotide (gapmeR)
that targets the junction of the rat circRNA and does not affect
the level of the linear Ins2 transcript (Fig. 4a and Supplementary
Fig. 1). This treatment did not alter cellular insulin content
(control gapmeR: 15 ± 7 vs. ci-Ins2 gapmeR: 19 ± 10 ng insulin/µg
protein, n= 5, mean ± s.d., two-tailed unpaired t-test), but
reduced insulin secretion in response to stimulatory glucose or
KCl concentrations (Fig. 4b) and tended to reduce prolactin-
stimulated β-cell proliferation (Fig. 4c). In contrast, basal insulin
secretion (Fig. 4b), as well as, basal and cytokine-induced islet
apoptosis (Fig. 4d) were not affected. We then assessed whether
human ci-INS also regulates β-cell insulin secretion. Despite the
expected variability in the secretory response of human islets
obtained from different donors, silencing this circRNA with two
distinct ci-INS junction gapmeRs targeting different sequences
from that of rat ci-Ins2 (Fig. 5a, d and Supplementary Fig. 1)
resulted in a decrease in glucose- or KCl-induced insulin secre-
tion (Fig. 5b, e). Instead, basal insulin secretion (Fig. 5b, e) and
cellular insulin content (Fig. 5c, f) were not affected by the two ci-
INS gapmeRs.
We next investigated the mechanisms through which ci-Ins2
regulates insulin secretion. RNA sequencing of rat islet cells
transfected with the ci-Ins2 gapmeR revealed the decreased
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Fig. 1 Insulin circular intronic RNAs are detectable in mouse, rat, and human islets. a Agarose gel electrophoresis picture showing circRNAs amplified by
qPCR using divergent primers targeting the intron 2 of mouse Ins2, rat Ins2, and human INS. b Loci of sequenced qPCR products of mouse Ins2 (mm10), rat
Ins2 (rn6), and human INS (hg38) intron 2 lariat and full-length circRNAs. The image was obtained using the UCSC genome browser (http://genome.ucsc.
edu). c Agarose gel electrophoresis picture of lariat mouse and rat ci-Ins2 and human ci-INS qPCR products amplified with over-junction primers. a, c
cDNA synthesis of islet RNA was performed with (+) or without (−) DNase treatment and with (+) or without (−) addition of reverse transcriptase (RT).
n= 1 independent experiment. Source data are provided as a Source Data file.
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(GEO accession GSE134699). Consistent with the observed
phenotype, the downregulated mRNAs were enriched for
transcripts originating from genes involved in insulin secretion.
In contrast, upregulated genes were mainly related to the
p53 signaling pathway (GEO accession GSE134699). Altered
mRNA levels of several key genes involved in insulin secretion
from glycolysis to exocytosis22–34 were validated by qPCR (Fig. 6a,
b). These included mRNAs coding for Ca2+ sensors (Syt4, Syt7,
and Pclo), Ca2+ channel subunits (Cacna1d), Na+/K+ ATPase
subunits (Atp1a1 and Atp1b3), and components involved in small
GTPase signaling (Rapgef4 and Rims2) and in the recruitment of
insulin granules for exocytosis (Unc13a). SYT7, PCLO,
CACNA1D, and UNC13A were also downregulated after knock-
ing down ci-INS in human islets with either gapmeR 1 or 2
(Fig. 6c, d).
Intronic circRNAs have been proposed to favor the transcrip-
tion of their parent genes and probably of other target genes13. To
assess whether low ci-Ins2 levels affect the transcription of Ins2
and of genes necessary for insulin secretion, we transfected rat
islet cells with a ci-Ins2 gapmeR and two days later treated them
for 2 h with 5-ethynyl uridine to tag newly transcribed RNAs. In
the case ofMidn, Atp1a1, Atp1b3, Cacna1d, Rapgef4, and Unc13a,
total mRNAs and newly synthesized transcripts were reduced to








































































































































Fig. 2 ci-Ins2 is a stable circular intronic RNA. a–c Mouse (gray circles) and rat (black circles) ci-Ins2 and Ins2, and human (clear circles) ci-INS and INS
were analyzed in islet RNA samples by qPCR. The expression of the circRNAs was assessed using over-junction primers. a Ct values in 10 ng RNA,
b relative circRNA/mRNA abundance (log10 scale), and c RNA levels in oligo dT (dT) cDNA relative to random primer (RP) cDNA measured by qPCR. n=
3 (c, human) and 4 (a–c (mouse and rat)) independent experiments. *p≤ 0.001 (a–c (ci-Ins dT) and *p= 0.011 (c, rat Ins2 dT) vs. Ins2, INS, or RP by two-
tailed unpaired or one-sample t-test. d Rat ci-Ins2 and Ins2 measured by qPCR in islet polyA RNA (clear circles) relative to non-polyA RNA (black circles).
n= 4 independent experiments. ***p= 0.000025 vs. non-polyA RNA by two-tailed one-sample t-test. e Rat ci-Ins2 and Ins2 (black circles) and human ci-
INS and INS (clear circles) measured by qPCR in RNase R-treated islet RNA relative to untreated RNA. n= 3 and 4 (rat Ins2) independent experiments.
#p= 0.01, ##p= 0.003, and ###p < 0.0001 vs. no RNase R-treated RNA and *p= 0.04 vs. ci-Ins2 or ci-INS by two-tailed one-sample or unpaired t-test.
f ci-Ins2 (black circles) and Ins2 intron 1 (gray circles) normalized to Hprt1, measured by qPCR, in rat islet cells after actinomycin D treatment relative to no
treatment (no AD). n= 5 independent experiments denoted as the mean. **p= 0.008 vs. no AD Ins2 intron 1, ##p= 0.003 (30min), ##p= 0.008 (1 h),
###p= 0.0003 (2 h), and ###p= 0.0001 (4 h) vs. ci-Ins2 at the corresponding time point by two-way ANOVA and Tukey post hoc test. a–f Data and
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Fig. 3 ci-Ins2 is specifically detected in β cells. a ci-Ins2 and (b) Ins2 normalized to Hprt1, measured by qPCR, in rat blood cells, plasma, and 19 tissues
relative to islet levels. ND= not detected. n= 4 independent experiments. *p < 0.0001 vs. islets by one-way ANOVA and Dunnett post hoc test. c ci-Ins2
(black circles), Ins2 (gray circles), and Gcg (clear circles) normalized to Hprt1, measured by qPCR, in rat α-cells relative to β-cells. n= 5 independent
experiments. ***p= 0.000005 (ci-Ins2), ***p= 0.0001 (Ins2), and ***p= 0.0002 (Gcg) vs. β-cells by two-tailed unpaired t-test. a–c Data and mean are
represented ± s.d. Source data are provided as a Source Data file.
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Fig. 4 ci-Ins2 is involved in rat β-cell secretory activity. a–d Dissociated rat islet cells were transfected with control (black circles) or ci-Ins2 (clear circles)
gapmeRs. Experiments were performed 48 h after transfection. a ci-Ins2 and Ins2 normalized to Hprt1, measured by qPCR, and expressed relative to control.
n= 6 independent experiments. ***p < 0.0001 by two-tailed one-sample t-test. b Insulin secretion in response to 2mM glucose (G), 20mMG, or 30mM
KCl represented as the fold change vs. control basal (2 mMG) condition. n= 5 independent experiments. *p= 0.018 and **p= 0.0007 as indicated, and
#p= 0.016, ###p < 0.0001 (20mMG) and ###p= 0.0004 (30mM KCl) vs. 2 mMG control by one-way ANOVA and Tukey post hoc test. c Basal and 48
h prolactin-stimulated β-cell proliferation determined by Ki67 and insulin staining. n= 9 independent experiments. ###p= 0.00005 vs. basal control
condition by one-way ANOVA and Tukey post hoc test. d Basal and 24 h cytokine-induced apoptosis determined by scoring pycnotic nuclei. n= 6
independent experiments. ###p= 0.0002 vs. basal control condition by one-way ANOVA and Games-Howell post hoc test. a–d Data and mean are
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Fig. 5 ci-INS is necessary for efficient human β-cell insulin secretion. a–f Dissociated human islet cells were transfected with control gapmeR (black
circles) or with ci-INS (clear circles) gapmeR 1 (a–c) or gapmeR 2 (d–f). Experiments were performed 48 h after transfection. a, d ci-INS and INS
normalized to HPRT1 and PPIA, measured by qPCR, and expressed relative to control in (a) ci-INS gapmeR 1 (n= 6 independent experiments) or (d) ci-INS
gapmeR 2 (n= 8 independent experiments). Data and mean are represented ± s.d. ***p= 0.0001 (a) and ***p= 0.00002 (d) by a two-tailed one-sample
t-test. b, e Insulin secretion in response to 2mM glucose (G), 20mMG, or 30mM KCl represented as the fold change vs. control basal (2 mMG)
condition in (b) ci-INS gapmeR 1 (n= 6 independent experiments) or (e) ci-INS gapmeR 2 (n= 8 independent experiments). *p= 0.018 (b) and *p= 0.011
(e) by two-tailed paired t-test. c, f Cellular insulin content normalized to protein content in control and (c) ci-INS gapmeR 1 (n= 6 independent
experiments) or (f) ci-INS gapmeR 2 (n= 8 independent experiments). Source data are provided as a Source Data file.
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effect of ci-Ins2 may be mediated at the transcriptional level.
Although the overall Ins2 mRNA was unchanged (Fig. 4a), we
found that inhibition of ci-Ins2 reduced the quantity of newly
synthesized Ins2 mRNA (Fig. 6e). The discrepancy between these
two observations may be explained by the high stability (half-life
≥29 h)35 and abundance of the Ins2 mRNA (second most
expressed gene in islets, GEO accession GSE134699). Therefore,
we assessed whether silencing of ci-Ins2 affects the amounts of
newly synthesized insulin. For this purpose, newly synthesized
proteins of rat islet cells transfected with control or ci-Ins2
gapmeRs were labeled with L-Azidohomoalanine (AHA).
Although we observed a tendency for a decrease in newly
synthesized insulin upon ci-Ins2 silencing, the effect did not reach
statistical significance (Fig. 6f). This suggests that the reduction in
insulin mRNA level may be insufficient to significantly impact on
insulin content.
Decreased expression of the voltage-dependent Ca2+ channel
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INS (Fig. 6b–d) suggests a defect in Ca2+ signaling. Consistent
with this hypothesis, ci-Ins2 knockdown led to a reduction in
Ca2+ peak and integrated load in the presence of stimulatory and
membrane-depolarizing K+ concentrations (Fig. 7a–c).
Next, we attempted to determine the mechanism(s) by which
ci-Ins2 regulates the transcription of their target genes. To exert
their cellular functions, circRNAs can bind microRNAs (miR-
NAs) or RNA-binding proteins (RBPs)2–4, and could potentially
also bind transcription factors (TFs). How circRNAs act is
probably dependent on their subcellular localization. In general,
exonic circRNAs, such as circHIPK3, which reside in the
cytoplasm have been shown to bind miRNAs, in contrast to
intronic circRNAs, which localize to the nucleus, and thereby
rather interact with nuclear RBPs16,36,37. A nuclear/cytoplasmic
fractionation performed in the murine β-cell line MIN6B1
revealed that, as expected, Gapdh, Ins2, and circHIPK3 were
localized in the cytoplasm while the lncRNA Malat1 was detected
in the nucleus38 (Fig. 8a). Interestingly, we found that ci-Ins2
predominantly resides in the nucleus and to a lesser extent in the
cytoplasmic fraction (65% vs. 35%, p= 0.0074, n= 4, Fig. 8a).
We next used a computational approach to search for potential
binding sites of miRNAs, TFs, and RBPs in ci-Ins2 and ci-INS
genomic sequences, and performed an enrichment analysis of
miRNAs and TFs targeting the qPCR-validated genes differen-
tially expressed after ci-Ins2 or ci-INS inhibition (Supplementary
Tables 3–7, Fig. 6b–d). Since it is present in the cytoplasm, ci-Ins2
could potentially exert its action by sponging miRNAs. However,
among the miRNAs predicted to target the genes deregulated
Fig. 6 ci-Ins2 and ci-INS inhibition affect islet gene expression. a Downregulated and upregulated genes (blue gene names) related to insulin secretion in
ci-Ins2 knockdown rat islet cells (modified KEGG pathway map 04911, https://www.genome.jp/kegg/pathway.html). Genes were selected from the
differential gene expression and KEGG pathway enrichment analyses of ci-Ins2 vs. control gapmeR rat islet RNA-sequencing data (n= 3, p < 0.05, GEO
accession GSE134699). b Expression of indicated genes normalized to Hprt1, measured by qPCR, in ci-Ins2 gapmeR transfected rat islet cells relative to
control. n= 5 (Atp1a1 and Syt7) and six independent experiments. c, d Expression of indicated genes normalized to HPRT1 and PPIA, measured by qPCR, in
(c) ci-INS gapmeR 1 (n= 6 independent experiments) or (d) ci-INS gapmeR 2 (n= 8 independent experiments) transfected human islet cells relative to
control. e 2 h newly transcribed mRNA levels of indicated genes normalized to Hprt1, measured by qPCR, in ci-Ins2 gapmeR transfected rat islet cells
relative to control. n= 3 independent experiments. f 2 h newly synthesized insulin protein levels, measured by ELISA, in ci-Ins2 gapmeR (clear circles and
squares) transfected rat islets relative to control (black circles and squares) and treated (or not) with AHA. n= 3 independent experiments. b–f Data and
mean are represented ± s.d. blue circles: p < 0.05 by two-tailed one-sample t-test. *p= 0.019 and **p= 0.001 by one-way ANOVA and Tukey post hoc


















































Fig. 7 ci-Ins2 knockdown decreases depolarization-induced Ca2+ influx. a–c Rat islets were transfected with control (black circles) or ci-Ins2 (clear
circles) gapmeRs and dissociated into single cells. Experiments were performed 48 h after transfection. a Representative Ca2+ imaging in control (black
line) or ci-Ins2 (red line) gapmeRs. b Ca2+ peak intensity and c integrated Ca2+ load after K+ stimulation. n= 18 (ci-Ins2 gapmeR) and 19 (control
gapmeR) cells from two independent experiments. Data and mean are represented ± s.d. *p= 0.015 and **p= 0.002 by two-tailed unpaired t-test. Source



























































Fig. 8 ci-Ins2 predominantly localizes to the nucleus and interacts with the RBP TDP-43. a Expression level of indicated genes, measured by qPCR, in
nuclear (clear circles) and cytosolic fractions (black circles) of MIN6B1 cells. n= 4 independent experiments. b RNA immunoprecipitation (IP) of TDP-43
or control IgG in MIN6B1 cell lysates. Left: ci-Ins2 and ciRS-7 RNA levels, measured by qPCR, in immunoprecipitated samples relative to IgG. TDP-43 IP
(clear circles) and IgG IP (black circles). n= 4 independent experiments. Right: Representative image of immunoprecipitated samples immunoblotted for
TDP-43. Data and mean are represented ± s.d. *p≤ 0.01 (a) and *p= 0.04 (b) by two-tailed unpaired t-test. Source data are provided as a Source Data file.
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upon ci-Ins2 silencing, only one potential binding site for miR-
139-3p, miR-188-5p, miR-296-5p, and miR-744 was identified in
ci-Ins2 or ci-INS sequences (Supplementary Tables 3, 4). These
miRNAs are barely detected in rodent and human islets (our
unpublished data) and there is no experimental evidence
indicating that these miRNAs may be involved in the regulation
of insulin secretion.
Although the interaction between intronic circRNAs and TFs
remains to be established, we also searched for possible TF
binding sites. We found that ci-Ins2 or ci-INS contain sequences
predicted to bind GLI2, SMAD3, and SMAD4 (Supplementary
Tables 5, 6). These TFs have been shown to modulate various
genes involved in insulin secretion39–41.
Computational analysis revealed that ci-Ins2 can potentially
interact with several RBPs (Supplementary Table 7). In particular,
we found that mouse ci-Ins2 is predicted to bind to the TAR
DNA-binding protein 43 kDa (TDP-43, encoded by Tardbp). If
one or few binding site mismatches are allowed the interaction
between TDP-43 and mouse ci-Ins2 appears to also be conserved
for rat ci-Ins2 and human ci-INS. Among the potential binding
partners, TDP-43 stand out as the best candidate to mediate the
actions of ci-Ins2. In fact, the knockout of this RBP in β-cells has
recently been shown to result in defective insulin secretion42.
Second, silencing of TDP-43 and ci-Ins2 results in a decrease in
the expression of a common set of genes and in particular of
genes involved in Ca2+ signaling and insulin exocytosis42. Third,
TDP-43 has already been shown to interact with intron lariats16.
None of the other RBPs identified in the computational analysis
possesses these properties. We nevertheless do not exlude that
other RBPs may mediate part of the effect of ci-Ins2.
To assess whether the blunted insulin secretion observed in our
model is mediated by the interaction with TDP-43, we compared
expression changes upon ci-Ins2 down-regulation in rat islets
(GEO accession GSE134699) with those in MIN6 cells depleted
from TDP-43 (GEO accession GSE125424). We identified 18
orthologous mouse-rat pairs whose expression change in the
same direction in both models, including Cacna1c, Pclo Pld1, and
Rapgef4 (Supplementary Table 8). Of note, genes consistently
differentially expressed between experiments are enriched in
calcium ion regulated exocytosis (p= 0.015) and insulin secretion
(p < 0.03) (Supplementary Table 9). To experimentally validate
the predicted interaction with TDP-43, we immunoprecipitated
the RNAs associated with this RBP from MIN6B1 cell lysates and
found a significant enrichment of ci-Ins2. This interaction was
specific since ciRS-7, an exonic circRNA involved in the control
of insulin secretion, was not pulled-down by the TDP-43
antibody (Fig. 8b). Taken together, these results suggest that at
least part of the effect of ci-Ins2 on the expression of genes
involved in calcium signaling and insulin release is mediated
through the interaction with TDP-43.
ci-Ins2 and ci-INS levels are reduced in type 2 diabetes. We
then assessed whether the level of ci-Ins2 and its parent gene Ins2
are modified in the islets of type 2 diabetes models exhibiting
impaired insulin secretion. The level of ci-Ins2 and Ins2 was
indeed reduced in the islets of diabetic Goto-Kakizaki (GK) rats, a
model in which type 2 diabetes develops in the absence of obe-
sity43 (Fig. 9a). ci-Ins2 was also reduced in obese and hypergly-
cemic db/db mice but remained unchanged in obese but
normoglycemic ob/ob mice8, while Ins2 was unchanged in db/db
mice and even increased in ob/ob mice (Fig. 9b, c). These results
demonstrate that the changes in ci-Ins2 do not simply reflect
those of its parent gene. Similar measurements were performed in
human islets from type 2 diabetes donors displaying high HbA1c
levels and compared to age- and BMI-matched non-diabetic
controls (Fig. 9d and Supplementary Table 10). ci-INS levels were
significantly lower and INS tended to be decreased in the islets
obtained from type 2 diabetic patients relative to controls
(Fig. 9e). Furthermore, ci-INS levels were inversely correlated
with HbA1c (Fig. 9f), whereas those of INS were not (Fig. 9g).
These findings suggest that inappropriate levels ci-INS, or its
rodent ortholog ci-Ins2, may contribute to β-cell dysfunction in
type 2 diabetes8,43,44.
Discussion
Insulin secretion plays a central role in the control of blood
glucose homeostasis and defects in this process promote the
appearance of diabetes mellitus. Thus, a better understanding of
the molecular mechanisms governing the release of this essential
hormone is of paramount importance to elucidate the causes of
this very common metabolic disorder. Recent findings from dif-
ferent laboratories, including ours, have shown that non-coding
RNAs contribute to the fine-tuning of insulin release6,7,45,46.
Here, we show that the insulin transcript itself is a source of
circRNAs that insure the release of appropriate amounts of the
hormone.
An increasing number of studies has reported the presence and
the functional involvement of circRNAs in a wide variety of
cells2–4, including pancreatic β-cells6,7,47. In this study, we sear-
ched for other relevant circRNAs involved in the control of β-cell
functions using a computational approach permitting de novo
annotation of all potential circRNAs detectable in our mouse islet
high-throughput RNA-sequencing data10. This annotation pre-
dicted the presence of a large number of circRNAs derived from
the sequences of key genes encoding proteins involved in insulin
biosynthesis and secretion5,11. These circRNAs were not detected
in our previous study that used a microarray approach and
included mostly ubiquitously expressed transcripts6. It should be
pointed out that in this study the samples used for RNAseq
analysis were not pre-treated with RNase R, which may poten-
tially introduce a bias. However, this may also be the case when
RNase R treatment is performed48. Indeed, while incubation of
total RNA with RNase R degrades linear transcripts and favors
the detection of circRNAs, this treatment may decrease the
chances to detect lowly abundant circRNAs and overestimate the
level of intron-derived circRNAs due to lariats being resistant to
the treatment. Thus, to obtain a comprehensive view of all
potential circRNAs expressed in islets, we elected to perform
data-analysis on untreated samples. The circularity and the
relative abundance of circRNAs were then confirmed by RNase R
treatment and qPCR. Recently, the presence of exonic circRNAs
produced from CHGA, PCSK2, and SLC30A8 genes was also
predicted by the annotation of RNA-sequencing data from
human α- and β-cells by Kaur et al.47. However, intronic cir-
cRNAs were not investigated in the Kaur study. Despite a few
differences, probably linked to the higher sequencing depth of our
data and to the use of different species, these findings confirm
that circRNAs can be generated from key islet genes.
Here, we elected to focus on intronic circRNAs derived from
the Ins2 transcript and to study in more detail the circRNA
formed by the intron 2 lariat that is detectable in both rodent (ci-
Ins2) and human islets (ci-INS). CircRNAs originating from the
Ins1 gene were also detected in our computational analysis but
were not investigated in this study. The Ins1 gene is expressed in
rodents and is not conserved in humans49. Moreover, in contrast
to the circRNAs originating from Ins2, the transcripts originating
from the Ins1 gene are exonic. Thus, if they have any role in β-
cells, they would likely have a different mode of action. As
expected, this circular transcript generated from the processing of
the insulin pre-mRNA was only detected in pancreatic β-cells.
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Lariats are formed during pre-mRNA splicing but are generally
linearized by the RNA-debranching enzyme DBR1 and subse-
quently degraded by RNA nucleases21,50,51. Indeed, inactivation
or depletion of DBR1 results in global lariat accumulation.
Interestingly, some lariats can escape debranching, as well as
degradation, and become stable functional circRNAs13. Accord-
ingly, rat ci-Ins2 was resistant to RNase R degradation, as was
human ci-INS, and was long lived. However, the mechanisms
permitting these circularized transcripts to escape debranching
and degradation remain to be defined.
Our data indicate that rat ci-Ins2 is not essential for β-cell
survival and has only minor, if any, effects on proliferation.
Instead, deficiency of this lariat in rat and human islet cells results
in blunted insulin release in response to nutrients (glucose) and/
or membrane-depolarizing compounds (KCl). Impaired insulin
secretion can be explained by changes in the expression of key
genes involved in the secretory pathway of β-cells. Indeed,
silencing of rat ci-Ins2, or human ci-INS, was associated with a
reduction in a striking number of mRNAs encoding essential
components of the secretory machinery of β-cells. These include
Ca2+ channel subunits regulating the entry of the cation upon
membrane depolarization, Ca2+ sensors, and different targets and
regulators of Rab3 GTPases. Most of these changes were
consistent in both species and were reproduced with different
gapmeR sequences, confirming the specificity of the effect.
Moreover, Ca2+ influx stimulated by K+ depolarization was
decreased in ci-Ins2 knockdown islets in agreement with the
downregulated expression of voltage-dependent Ca2+ channels.
Little is known about the mode of action of intronic circRNAs.
Lariat-derived circRNAs have been shown to act as decoys of
RBP16, by regulating pri-miRNA processing to mature miR-
NAs17, or as regulators of RNA splicing18. Moreover, intronic
circRNAs were reported to be preferentially localized in the
nucleus and to directly interact with the transcriptional
machinery13. Accordingly, ci-Ins2 was found to be more abun-
dant in the nucleus and part of its effects appear to be exerted at
the transcriptional level by interacting with the RBP TDP-43.
Nuclear depletion of this RBP is the histopathological hallmark of
amyotrophic lateral sclerosis (ALS). Since ALS patients display
impaired glucose homeostasis, Araki and colleagues investigated
the potential involvement of TDP-43 in the regulation of insulin
secretion. They observed that ALS subjects have reduced early-
phase insulin release, which correlates with a decrease in TDP-43
levels in β-cells. Moreover, knock-down of the Tardbp gene
(encoding TDP-43) in mice did not affect insulin content but
resulted in blunted insulin secretion in vivo and ex vivo and in a
0
ci-Ins2
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Fig. 9 ci-Ins2 and ci-INS levels are low in type 2 diabetes rodent models and human donors. a–c Islet ci-Ins2 and Ins2 normalized to Hprt1, measured by
qPCR, and expressed relative to control in (a) type 2 diabetes Goto-Kakizaki (clear circles) relative to Wistar (black circles) rats (n= 3), b type 2 diabetes
db +/+ (clear circles) relative to db +/− (black circles) mice (n= 5 (db +/+) and 6 (db +/−), and (c) ob +/+ (clear circles) relative to ob −/− (black
circles) mice (n= 6). d Characteristics of human donors (n= 8 (type 2 diabetes (T2D) HbA1c) and 9, Supplementary Table 10). e Islet ci-INS and INS
normalized to HPRT1 and 18S, measured by qPCR, in type 2 diabetes (clear circles) relative to control (black circles) donors (n= 9). a–e Data and mean are
represented ± s.d. *p= 0.022 and **p≤ 0.01 by two-tailed unpaired t-test. f, g Correlation of (f) ci-INS and (g) INS relative islet RNA levels with HbA1c in
control (black circles) and type 2 diabetes (clear circles) donors (n= 8 (type 2 diabetes) and 9 (control)). p < 0.05 by two-tailed Pearson test was
considered significant. Source data are provided as a Source Data file.
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reduced expression of Cacna1c. Finally, overexpression of Cav1.2
restored early-phase insulin secretion in Tardbp-depleted MIN6
cells. Among the genes deregulated in islet cells upon ci-Ins2
silencing, 18 are common to Tardbp-depleted MIN6 cells and are
related to calcium ion regulated exocytosis and insulin secretion
pathways. While upon silencing of ci-Ins2 and TDP-43 most
genes directly involved in the regulation of insulin secretion
display changes in the same direction (in particular Rapgef4, Pld1,
Pclo, and Cacna1c), some of the other genes do not. It should be
pointed out that in our study, we measured gene expression in rat
islet cells while Araki et al.42 analyzed the impact of TDP-43
silencing in the mouse insulin-secreting cell line MIN6. More-
over, our analysis was carried out by RNA sequencing while Araki
et al. used a microarray approach. These experimental differences
may potentially explain part of the discrepancies. Moreover,
TDP-43 is known to regulate the expression of a large set of
genes52 and most of the effects of this RBP occur also in cells that
do not express insulin. Thus, even in β-cells part of these changes
are certainly independent of ci-Ins2. Taken together, our findings
suggest that at least part of the effect of ci-Ins2 may be mediated
by TDP-43. The precise mechanisms through which ci-Ins2 and
TDP-43 regulate insulin release remains to be elucidated. In
principle, ci-Ins2 could act both as a co-activator or a decoy for
TDP-43. Since TDP-43 is known to associate with a large number
of transcripts, ci-Ins2 could potentially guide TDP-43 towards the
interaction with certain transcripts but prevent its binding to
others. However, our data would fit more easily with a model in
which ci-Ins2 functions as a co-activator because the expression
of most genes involved in insulin secretion is reduced upon
silencing of TDP-43 or ci-Ins2.
Our computational predictions suggest that ci-Ins2/ci-INS
contains potential binding sites for the TFs SMAD4, SMAD3, and
GLI2. Based on our analysis it is not possible to determine
whether these TFs would bind the circRNA or the corresponding
genomic sequence. However, since some TFs have been proposed
to bind to RNA53,54 we included the computational analysis to
provide the reader with a comprehensive picture of all possible
partners of the circRNA. SMAD3 and GLI2 were reported to
impair insulin biosynthesis and glucose-stimulated secretion,
partly through repressing insulin transcription39,40. In the present
study, silencing of ci-Ins2 resulted in a small but significant
decrease in newly transcribed Ins2, but did not affect insulin
content nor insulin biosynthesis. Since it has been reported that
pre-existing insulin mRNA is preferentially translated upon glu-
cose stimulation55 we cannot fully exclude that, as previously
shown for other intronic circRNAs13, prolonged reduction in ci-
Ins2 affects the expression of its parent gene and would result,
over a long period, in a decrease in β-cell insulin content.
A fraction of ci-Ins2 appears to reside in the cytoplasm, fitting
with the observations that lariats can in some circumstances be
exported to this cellular compartment. Thus, we cannot exclude
that ci-Ins2 could also be involved in the regulation of some post-
transcriptional events as it has been demonstrated for exonic
circRNAs. However, the effect of ci-Ins2 on insulin secretion is
unlikely to be mediated by sponging the miRNAs that are pre-
dicted to interact with this intronic circRNA, since they are barely
expressed in β-cells and none of them has been reported to play
important roles in insulin secretion.
Interestingly, the level of ci-Ins2 is not modified in normo-
glycemic obese mice, but is reduced in the islets of rodent models
of type 2 diabetes as observed for circHIPK3 and ciRS-76. This
finding was confirmed in human. Indeed, the level of ci-INS was
found to be significantly lower in the islets of type 2 diabetes
donors and to be inversely correlated to HbA1c levels. This
suggests that reduced ci-Ins2 and ci-INS may contribute to β-cell
failure in rodent and human type 2 diabetes8,43,44.
In conclusion, our data indicate that the primary transcript of
the insulin gene is not only providing the code for insulin bio-
synthesis, but is also generating a circRNA that is necessary to
ensure an efficient release of this hormone under stimulatory
conditions (Fig. 10). Future experiments will have to determine
whether this phenomenon is restricted to β-cells or whether
circRNAs with analogous regulatory functions are operating also
in other endocrine cells. Elucidating the role of this and other
circRNAs will contribute to a better understanding of the etiology
of diabetes mellitus and potentially of other endocrine diseases.
Methods
CircRNA annotation. circRNAs were annotated in high-throughput RNA-
sequencing data from mouse islets (GEO accession GSE92602)10 by computational
detection using two separate circRNA algorithms: CIRI256 and find_circ57. Only
circRNAs detected by both algorithms were considered and two or more backsplice
spanning reads were required to call circRNAs in individual samples.
Animals. Male Wistar rats and C57Bl/6N mice aged 12 weeks were acquired from
Janvier Labs, male C57BL/KsJ db/db, C57BL/6J ob/ob, and their respective control
db +/− and ob −/− mice aged 13–16 weeks from the Garvan Institute breeding
colonies, and female Goto-Kakizaki (GK/MolTac) and control Wistar rats aged
8 weeks from Taconic Europe. Animals were housed under standard temperature
(20–24 °C) and humidity (40–70%) conditions on a 12-h light/dark cycle with free
access to chow diet and water. Procedures were performed in agreement with the
NIH guidelines and approved by the Swiss research council and veterinary offices,
the national health and medical research council of Australia, and the ethics
committee of Lund University.
Human pancreatic islets. Human islets from male and female type 2 diabetes and
aged- and BMI-matched non-diabetic control cadaver donors (Supplementary
Table 10) were provided by the Human Tissue Lab of EXODIAB/Lund University
Diabetes Centre through the Nordic Network for Islet Transplantation of Uppsala
University. For in vitro experiments, human islets from male and female non-
diabetic cadaver donors (Supplementary Table 10) were provided by the Centre
Européen d’Etude du Diabète of Strasbourg University (isolation protocol
authorization for scientific research #PFS12-0013), the Department of Clinical and
Experimental Medicine of Pisa University, and the European Consortium for Islet
Transplantation of Hôpitaux Universitaires de Genève through the JDRF award 31-
2008-416 (ECIT Islet for Basic Research program). Informed consent was pre-
viously provided by all donors. Procedures complied with relevant ethical regula-
tions and were approved by the ethics committees of the corresponding
Universities.
Pancreatic islet isolation, dissociation, and sorting. Mouse and rat islets were
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Fig. 10 ci-Ins is required for optimal insulin secretion. In β-cells, the
primary insulin transcript is processed to generate the mature mRNA that is
translated for insulin biosynthesis. In parallel, the second intron excised
from the primary insulin transcript forms a stable circular RNA (ci-Ins2/ci-
INS) that associates with the RBP TDP-43 and controls the expression of
genes necessary for optimal insulin release in response to secretory stimuli.
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gradient and handpicking58. When needed, rodent and human islets were dis-
sociated into single cells by incubation in Ca2+/Mg2+ free phosphate-buffered
saline, 3 mM EGTA, and 0.002% trypsin (Gibco) for 5–10 min at 37 °C. Enriched
fractions of α- and β-cells were obtained by Fluorescence-Activated Cell Sorting
(FACS) of dissociated islet cells based on β-cell autofluorescence as previously
described59,60. FACS purity was assessed by double immunofluorescence staining
and scoring of α- (glucagon-positive) and β- (insulin-positive) sorted cells using
mouse anti-glucagon (Abcam ab10988, 1:1000), guinea pig anti-insulin (Dako
A0564, 1:100), goat anti-mouse IgG Alexa Fluor 555 (Thermo Fisher A-21422,
1:500), and goat anti-guinea pig IgG Alexa Fluor 488 (Thermo Fisher A-11073,
1:500) antibodies. On average, β-cell fractions contained 99.1 ± 0.9% insulin-
positive cells and 0.6 ± 0.6% glucagon-positive cells, while α-cell-enriched fractions
contained 10.6 ± 8.2% insulin-positive cells and 88.8 ± 8.2% glucagon-positive cells.
Rodent islet cells were cultured in RPMI 1640 GlutaMAX medium (Gibco) sup-
plemented with 10% fetal bovine serum (Gibco), 100 U/mL penicillin and 100 µg/
mL streptomycin (Gibco), 1 mM sodium pyruvate (Sigma), and 10 mM Hepes
(Sigma). Instead, human islet cells were cultured in CMRL 1066 medium (Gibco)
supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL
streptomycin, 2 mM L-glutamine (Gibco), and 10 mM Hepes.
Culture of MIN6B1 cells. The murine insulin-secreting cell line MIN6B161 was
cultured in DMEM-Glutamax medium (Invitrogen), supplemented with 15% fetal
calf serum (Gibco), 50 U/ml penicillin and 50 µg/ml streptomycin (Gibco), and 70
µM β-mercaptoethanol (Sigma). MIN6B1 cells were tested negative for myco-
plasma contamination.
Cell transfection. Dissociated rat and human islet cells were transfected using
Lipofectamine RNAiMAX (Thermo Fisher) with either control or species-specific
ci-Ins2 and ci-INS antisense LNA oligonucleotides (gapmeRs, Qiagen) with the
following sequences: control gapmeR: 5′-AACACGTCTATACGC-3′, rat ci-Ins2
gapmeR: 5′-GCTTACAGACACATAG-3′, human ci-INS gapmeR 1: 5′-GCTCA
CGGACACAGGA-3′, and human ci-INS gapmeR 2: 5′-CGGTTGGCTCACGG
AC-3′. Cells were then cultured for 48 h before RNA extraction or functional
assays.
Blood and tissue sampling. Rat blood was collected by post-mortem cardiac
puncture and centrifuged to separate blood cells and plasma whilst tissues were
dissected and immediately frozen in liquid nitrogen. Thereafter, samples were
disrupted and homogenized in QIAzol lysis reagent (Qiagen) and conserved at
−80 °C until RNA extraction.
Total RNA and qPCR. Total RNA from islet cells, blood cells, plasma, and tissue
samples were extracted with the miRNeasy kit (Qiagen), treated with DNase
(Promega or Qiagen), and reverse transcribed with an M-MLV reverse tran-
scriptase and random primers (Promega) or with the High Capacity cDNA kit with
RNase inhibitor (Thermo Fisher). Quantitative PCR (qPCR) was performed using
the SsoAdvanced Universal SYBR Green Supermix (BioRad) or the PowerUP SYBR
Green Master Mix (Applied Biosystems). The number of circRNA and mRNA
molecules per ng of rodent islet RNA was evaluated employing a corresponding
standard curve. Primer sequences are listed in Supplementary Table 11. Selected
qPCR products were loaded in agarose gels for electrophoresis, purified with the
QIAquick gel extraction kit (Qiagen), and sequenced. The sequencing files were
analyzed using Chromas (2.6.5).
RNA circularity. Total RNA from islets was treated with DNase and reverse
transcribed with random or oligo dT primers (Promega) followed by qPCR
amplification, or incubated with or without 2.5 U/µg RNase R (Epicentre) at 37 °C
for 15 min or separated into polyA RNA and non-polyA RNA (unbound to oligo
dT beads) using the Poly(A)Purist MAG kit (Thermo Fisher AM1922) followed by
RNA extraction, DNase treatment, reverse transcription with random primers, and
qPCR amplification.
RNA stability. Dissociated islet cells were cultured with 10 µg/mL actinomycin D
(Sigma) for 10 min, 30 min, 1 h, 2 h, and 4 h, and harvested for total RNA
extraction followed by DNase treatment, reverse transcription using random pri-
mers, and qPCR amplification.
Nascent RNA pull down. Transfected islet cells were treated with 200 µM 5-
ethynyl uridine (EU) for 2 h to tag newly transcribed RNA. Thereafter, cells were
harvested for total RNA extraction. EU-RNA was then biotinylated and pulled
down using the Click-iT Nascent RNA Capture kit (Thermo Fisher C10365). The
EU-RNA captured on streptavidin beads was reverse transcribed with random
primers and target RNA levels were measured by qPCR.
Nascent insulin protein assay. After 48 h of transfection with control or ci-Ins2
gapmeRs, rat islet cells were treated for 2 h with 100 μM of L-Azidohomoalanine
(AHA) (Jena Bioscience, CLK-AA005) in methionine-free RPMI medium (Thermo
Fisher, A1451701) to tag newly synthesized proteins. Then, proteins were collected
in 1% SDS−50 mM Tris-HCl buffer and biotinylated by click reaction using the
Click-iT Protein Analysis Detection kit (Thermo Fisher, 3337). Biotinylated pro-
teins were pulled down with an excess of streptavidin-coated beads (Dynabeads
MyOne Streptavidin C1, Thermo Fisher, 65001) and eluted from the beads by
boiling the samples for 3 min in 0.1% SDS in PBS. Pulled-down biotinylated insulin
was quantified by ELISA (Mercodia, 10-1250-10).
Insulin secretion and content. Transfected islet cells were first incubated at 37 °C
for 45 min in a Krebs-Ringer bicarbonate buffer (KRBH) containing 25 mM
HEPES, pH 7.4, 0.1% BSA, and 2 mM glucose (Sigma). Thereafter, the cells were
incubated at 37 °C for 45 min in KRBH-BSA solutions with 2 mM (basal) or 20
mM (stimulatory) glucose, or with 2 mM glucose and 30 mM (stimulatory) KCl
(Sigma). After incubation, supernatants were collected. The cells kept at basal
glucose were harvested using acid ethanol (75% ethanol, 0.55% HCl), and those
incubated at stimulatory glucose were lysed using Triton X-100 lysis buffer to
determine insulin and protein contents, respectively. Insulin levels were measured
by ELISA (Mercodia) and cellular protein contents by Bradford assay (Thermo
Fisher).
Ca2+ imaging. Transfected islet cells were washed with KRBH containing 2.8 mM
glucose and incubated with 1 μM Fura-2 AM (Thermo Fisher) in KRBH at 37 °C for
30 min to measure intracellular Ca2+. The cells were then washed with KRBH and
perfused with KRBH containing 70mMK+ at a flow rate of 1 mL/min at 32 °C.
Fura-2 AM fluorescence was monitored at 340 and 380 nm (excitation wavelengths)
upon Ca2+ binding, and the emitted light signals were read at 510 nm. Polychrome
V high speed switching monochromator on a Nikon microscope equipped with an
Andor ER-BOB-100 trigger box, an Andor camera Ixon3, and the Andor iQ (2.5.1)
software were used for imaging. The area under the curve (AUC) was calculated as
AUC= Σ [0.5(Ratio340/380n+ Ratio340/380n−1) × (tn−tn−1)] (1), in which tn
represents the time intervals.
β-cell proliferation. Proliferative β-cells were detected by immunostaining of
transfected islet cells with rabbit anti-Ki67 (Abcam ab15580, 1:1500), guinea pig
anti-insulin (Dako A0564, 1:100), goat anti-rabbit IgG Alexa Fluor 488 (Thermo
Fisher A-11008, 1:500), and goat anti-guinea pig IgG Alexa Fluor 555 (Thermo
Fisher A-21435, 1:500) antibodies. Coverslips were mounted on microscope glass
slides with Fluor-Save mounting medium (VWR International SA) and were
visualized with a Zeiss Axiovision fluorescence microscope. Prolactin (500 ng/mL,
Sigma) was used to stimulate proliferation for 48 h. A minimum of 800 cells were
counted per condition.
Islet cell apoptosis. Cell apoptosis was assessed by incubating transfected islet
cells with 1 mg/mL Hoechst 33342 (Thermo Fisher) at 37 °C for 3 min and scoring
the fraction of cells displaying pycnotic nuclei under a fluorescence microscope.
A mix of the pro-inflammatory cytokines (PeproTech) IL-1β (0.1 ng/mL), TNF-α
(10 ng/mL), and IFN-γ (30 ng/mL) was used to induce cell death for 24 h. A
minimum of 300 cells were counted per condition.
RNA sequencing. Libraries from total RNA of transfected Wistar islet cells were
prepared and sequenced by the Lausanne Genomic Technologies Facility with the
TruSeq Stranded mRNA Library Prep kit and a HiSeq 2500 instrument for a single
end run of 125 cycles using the SBS chemistry v4 (Illumina). To determine tran-
script expression levels, reads were mapped to the rat transcriptome (ENSEMBL
92, rn6) using STAR62 (2.5.3a) and quantified with RSEM63 (1.3.0). To identify
differentially expressed genes, reads were mapped to the rat genome (rn6) using
HISAT64 (2.1.0) and gene counts for rat genes (ENSEMBL 92, rn6) estimated using
HTseq65 (0.10.0). Normalization and differential gene expression (FDR < 0.05)
were performed using DESeq266 (v.1.12.4). Gene enrichment analysis for sig-
nificantly up or down-regulated genes relative to all islet expressed genes was
carried out using the DAVID webserver67 (6.8).
The overlap and direction of changes between genes differentially expressed
upon ci-Ins2 knockdown (GEO accession GSE134699) were compared to those of
TDP-43 knockdown in MIN6 cells (GEO accession GSE12542442) (Supplementary
Table 8). The Biological Process GO term for the genes that change consistency
between the two experiments (Supplementary Table 9) were analyzed using the
DAVID webserver68,69 (6.8).
Subcellular fractionation. Nuclear and cytosolic fractions of MIN6B1 cells were
obtained using the PARIS Kit (Thermo Fisher) followed by RNA extraction, reverse
transcription and qPCR as previously described.
Binding site prediction and enrichment analysis. The lariat 5′-3′ genomic
sequences of mouse and rat ci-Ins2 and of human ci-INS (Source Data Fig. 1b)
were used to predict putative binding sites of miRNAs, RBPs, and transcription
factors (TFs) in ci-Ins2 and ci-INS. For miRNAs expressed in β-cells6, a custom
python script based on a sliding window was utilized to detect a perfect match of
miRNA seeds (6 nt) and their position relative to the 5′-end of ci-Ins2 or ci-INS
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19381-w ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:5611 | https://doi.org/10.1038/s41467-020-19381-w | www.nature.com/naturecommunications 11
sequences. For RBPs and TFs, the motif scanning tool FIMO70 (5.1.0) was used
together with the ATtRACT71 and Jaspar72 motif databases, and the relative
position, p value (<10−4) and sequence of each match are reported. To identify
miRNAs and TFs targeting the differentially expressed genes shown in Fig. 6, a
gene-set enrichment analysis for binding motifs was performed using Enrichr
webserver73 (2016).
RNA immunoprecipitation and Western Blot. RNA immunoprecipitation was
performed using the Imprint RNA Immunoprecipitation Kit (Sigma). In brief,
MIN6B1 cell lysates (1 × 107 cells) were immunoprecipitated with 5 µg of rabbit
IgG or rabbit anti-TDP43 (Abcam ab190963) antibodies, which were pre-bound to
protein A agarose beads. Following an overnight incubation with respective anti-
bodies, equal proportions of the sample volume were used for protein and RNA
isolations, respectively. For Western Blot analysis, the immunoprecipitated pro-
teins were eluted by heating the samples to 95 °C for 5 min in 2x Laemmli Buffer
supplemented with β-mercaptoethanol. The samples, including a MIN6B1 input
cell lysate, were run on a SDS-PAGE gel (Bio-Rad, 4561086) and transferred onto a
nitrocellulose membrane (Bio-Rad, 1620117) which was subsequently blocked for
1 h in 5% BSA in TBS-T and incubated overnight at 4 °C with the anti-TDP43
antibody (1:1000 in blocking solution). Afterwards, the membrane was incubated
for 1 h with the HRP-conjugated goat anti-rabbit IgG (H+ L, Jackson Immu-
noResearch 211-035-109, 1:10000 in blocking solution) and subsequently revealed
using the ECL substrate (Pierce, 32106). For qPCR analysis, RNA molecules bound
to immunoprecipitated proteins were eluted in Qiazol followed by RNA isolation,
reverse transcription and qPCR as previously described.
Statistical analysis. Data are represented as the mean or as individual values and
mean ± standard deviation (s.d.). GraphPad Prism 7 and IBM SPSS Statistics
25 software were used to plot and analyze data with suitable statistical tests. Data
normality was determined with a Shapiro-Wilk test, and homogeneity of variances
with a Levene test. A two-tailed one-sample t-test was used to compare a data set to
a control value settled to 1, and two-tailed paired or unpaired t-tests for comparing
two data sets. One- or two-way ANOVA followed by Tukey, Dunnett, or Games-
Howell post hoc tests were used to compare multiple data sets. Correlation of data
sets was assessed by a two-tailed Pearson test. Differences between data sets were
considered significant whenever p values were inferior to 0.05.
Reporting summary. Additional information on the design of this study is available in
the Nature Research Reporting Summary of this article.
Data availability
All data supporting the findings of this study are available within the article and
its supplementary information files or from the corresponding author upon request.
RNA-sequencing data and annotated circRNAs are available under the Gene Expression
Omnibus (GEO) accession code GSE134699. The source data underlying Supplementary
Fig. 2 (ab1 raw sequencing files) are provided as a Supplementary Data compressed
archive file. Source data are provided with this paper.
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